SCHEMBL25517229

SCHEMBL25517229

c1ccc(-c2cccc(N(c3cccc(-c4ccccc4)c3)c3cccc4c3ccc3oc5ccccc5c34)c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 5/20 0.38
▸ PLA2G4A P47712 5/20 0.38
▸ PLA2G10 O15496 1/20 0.36
▸ HPGD P15428 4/20 0.34
▸ SMN1; SMN2 Q16637 3/20 0.34
▸ NPC1 O15118 2/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ CYP3A4 P08684 2/20 0.34
▸ GABRP O00591 1/20 0.34
▸ GABRD O14764 1/20 0.34
▸ CA12 O43570 1/20 0.34
▸ TNKS O95271 1/20 0.34
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ ABCB1 P08183 1/20 0.34
▸ PARP1 P09874 1/20 0.34
▸ ADORA3 P0DMS8 1/20 0.34
▸ AR P10275 1/20 0.34
▸ CYP19A1 P11511 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25516015 0.96 PLA2G2A (0.39) PLA2G2APLA2G4APLA2G10HPGDSMN1; SMN2
SCHEMBL25517128 0.95 AHR (0.36) PLA2G2APLA2G4APLA2G10HPGDSMN1; SMN2
SCHEMBL23511889 0.92 PGR (0.36) PLA2G2APLA2G4APLA2G10HPGDSMN1; SMN2
SCHEMBL25869756 0.91 TDP1 (0.36) PLA2G2APLA2G4APLA2G10HPGDCYP3A4
SCHEMBL27011594 0.91 PLA2G2A (0.37) PLA2G2APLA2G4APLA2G10HPGDSMN1; SMN2
SCHEMBL25517232 0.90 PLA2G2A (0.37) PLA2G2APLA2G4APLA2G10HPGDSMN1; SMN2
SCHEMBL25869183 0.90 PLA2G2A (0.36) PLA2G2APLA2G4APLA2G10HPGDSMN1; SMN2
SCHEMBL25872492 0.90 ALDH1A1 (0.33) PLA2G2APLA2G4APLA2G10HPGDSMN1; SMN2
SCHEMBL24540127 0.90 PLA2G2A (0.36) PLA2G2APLA2G4APLA2G10HPGDSMN1; SMN2
SCHEMBL23512024 0.89 PGR (0.36) PLA2G2APLA2G4APLA2G10HPGDTNKS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240215441-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2024-06-27 — — US disclosed
EP-4243102-A1 ORGANIC LIGHT-EMITTING DEVICE Lg Chem, Ltd. (KR) 2023-09-13 — — EP disclosed
EP-4235830-A1 ORGANIC LIGHT-EMITTING DEVICE Lg Chem, Ltd. (KR) 2023-08-30 — — EP disclosed
WO-2023085881-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2023-05-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240215441-A1 ORGANIC LIGHT EMITTING DEVICE CRY2, CRY1, AHR PLA2G2A 2355/4885PLA2G4A 2625/4885PLA2G10 1662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback